Omega Life Science has developed an aerosol drug-delivery system for systemic, local, and CNS targeting.

The system consists of a proprietary inhaler and a tailor-made formulation technology.The companys aerosolization technology has enabled development of a proprietary inhaler platform, Alphazer, for producing aerosols with parameters leading to improved patient experience and enhanced therapeutic effect.The Alphazer is an inhaler platform that produces submicron- to micron-sized droplets and submicron- to nano-sized dry particles of the desired pharmaceutical compound.

The inhaler is a handheld device that is distributed with proprietary disposable drug cartridges.Omega Life Science is a subsidiary of Nanosol Ltd.